Dental Anesthesia Dosage Calculator
Weight-based maximum safe dose calculator for all major dental local anesthetics. Calculates mg limit and maximum cartridges for pediatric and adult patients. Prevents LAST (Local Anesthetic Systemic Toxicity).
Clinically reviewed by Dr. Nikhil Mahajan, PT, MPT · Jan 15, 2025Select Local Anesthetic Agent
Dental Local Anesthetic Maximum Dose Reference
| Agent | Concentration | Max Dose (mg/kg) | Absolute Max (mg) | mg per 1.8 mL Cartridge | Age Restriction |
|---|---|---|---|---|---|
| Lidocaine 2% w/ Epi | 20 mg/mL | 7 mg/kg | 500 mg | 36 mg | All ages (use caution in neonates) |
| Lidocaine 2% Plain | 20 mg/mL | 4.4 mg/kg | 300 mg | 36 mg | All ages |
| Articaine 4% w/ Epi | 40 mg/mL | 7 mg/kg | 500 mg | 72 mg | ≥ 4 years (limited data in younger children) |
| Mepivacaine 3% Plain | 30 mg/mL | 6.6 mg/kg | 400 mg | 54 mg | All ages |
| Mepivacaine 2% w/ Epi | 20 mg/mL | 6.6 mg/kg | 400 mg | 36 mg | All ages — use caution in cardiac disease |
| Bupivacaine 0.5% w/ Epi | 5 mg/mL | 2 mg/kg | 90 mg | 9 mg | ≥ 12 years — NOT recommended for pediatric use |
Dental Local Anesthetic Dosing — Why Weight Matters
The maximum safe dose of any dental local anesthetic is determined by the patient's body weight in kilograms. This weight-based calculation is critical because local anesthetics reach systemic circulation via absorption from injection sites, and plasma levels that cause toxicity (LAST) are determined by total body drug load relative to body mass. In adults weighing over 70 kg, the absolute dose ceiling (e.g., 500 mg for lidocaine) is usually reached before the weight-based limit — but in children, the weight-based calculation is always the limiting factor and must be calculated precisely.
The 6 Major Dental Local Anesthetics Explained
- Lidocaine 2% with Epinephrine 1:100,000 (36 mg/cartridge): The most widely used dental LA worldwide. Maximum 7 mg/kg, absolute max 500 mg. Each 1.8 mL cartridge contains 36 mg of lidocaine. Duration: 60–90 min pulpal, 3–5 hours soft tissue. The vasoconstrictor epinephrine reduces systemic absorption and extends duration.
- Lidocaine 2% Plain (36 mg/cartridge): Without vasoconstrictor, systemic absorption is faster — maximum dose drops to 4.4 mg/kg (absolute max 300 mg). Used when epinephrine is contraindicated. Shorter duration: 5–10 min pulpal, 1–2 hours soft tissue.
- Articaine 4% with Epinephrine 1:100,000 (72 mg/cartridge): The most potent available dental LA by concentration. Each cartridge contains twice the drug of 2% lidocaine — reach the maximum dose in half the cartridges. Maximum 7 mg/kg, absolute max 500 mg. Not recommended under age 4. Excellent for mandibular infiltration due to high lipid solubility.
- Mepivacaine 3% Plain (54 mg/cartridge): Preferred when vasoconstrictor is contraindicated (cardiovascular disease, thyroid disease, allergy to sulfite preservatives). Maximum 6.6 mg/kg, absolute max 400 mg. Shorter duration than lidocaine with epi but has intrinsic mild vasoconstrictive properties.
- Mepivacaine 2% with Epinephrine 1:20,000: Higher epinephrine concentration than other agents — use with caution in cardiac patients. Same dose limits as plain mepivacaine.
- Bupivacaine 0.5% with Epinephrine 1:200,000 (9 mg/cartridge): The most cardiotoxic dental LA — extremely low maximum dose of 2 mg/kg, absolute max 90 mg. Reserved for providing prolonged post-operative analgesia in adults. NOT recommended for patients under 12 years of age.
LAST — Local Anesthetic Systemic Toxicity
LAST is a life-threatening emergency that can occur when excessive local anesthetic enters the systemic circulation. Causes include: inadvertent intravascular injection, excessive total dose, rapid vascular absorption (especially in inflamed or highly vascular tissue), or delayed redistribution in pediatric patients. LAST symptoms progress: tinnitus → perioral numbness → metallic taste → agitation → seizures → CNS depression → cardiovascular toxicity → cardiac arrest. Treatment: stop injection immediately, call for help, 100% oxygen, benzodiazepines for seizures, Intralipid 20% emulsion therapy for cardiovascular collapse (1.5 mL/kg IV bolus).
Special Considerations for Pediatric Patients
- Children's lower body mass means the maximum cartridge count is often 1–3 cartridges for small children — dental teams must calculate precisely before every pediatric procedure
- Articaine should not be used in children under 4 years due to limited safety data
- Bupivacaine should not be used in children under 12 years due to its narrow safety margin and high cardiotoxicity
- Children with hepatic disease metabolize amide anesthetics more slowly — reduce dose accordingly
- Always use the lowest effective dose — start with one cartridge and assess effect before administering additional doses